Hyperphosphatemia remains a major challenge in patients with Chronic Kidney Disease (CKD) receiving maintenance hemodialysis, affecting nearly half of this population. Elevated serum phosphate is an established independent risk factor for all cause mortality and has been strongly linked to cardiovascular morbidity, including vascular calcification and adverse cardiovascular events such as myocardial infarction and stroke [1].